Laurent Arnaud

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen et al. · Annals of the Rheumatic Diseases · 2023 · 933 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Julien Haroche, Frédéric Charlotte, Laurent Arnaud et al. · Blood · 2012 · 693 citations

Medicine, Genetics, Molecular Genetics +10

Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease

Eli L. Diamond, Lorenzo Dagna, David M. Hyman et al. · Blood · 2014 · 586 citations · Full text

Medicine, Pathology, Pulmonology +3

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

Julien Haroche, Fleur Cohen‐Aubart, Jean‐François Emile et al. · Blood · 2012 · 530 citations

Medicine, Molecular Biology, Molecular Genetics +10

CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients

Laurent Arnaud, B. Hervier, A. Néel et al. · Blood · 2011 · 384 citations · Full text

Pharmacy, Neurology, Neuroimmunology +4